Literature DB >> 25070262

A standardized method for in vivo mouse pancreas imaging and semiquantitative β cell mass measurement by dual isotope SPECT.

Iris Mathijs1, Catarina Xavier, Cindy Peleman, Vicky Caveliers, Maarten Brom, Martin Gotthardt, Pedro L Herrera, Tony Lahoutte, Luc Bouwens.   

Abstract

PURPOSE: In order to evaluate future β cell tracers in vivo, we aimed to develop a standardized in vivo method allowing semiquantitative measurement of a prospective β cell tracer within the pancreas. PROCEDURES: 2-[(123)I]Iodo-L-phenylalanine ([(123)I]IPA) and [Lys(40)([(111)In]DTPA)]exendin-3 ([(111)In]Ex3) pancreatic uptake and biodistribution were evaluated using SPECT, autoradiography, and an ex vivo biodistribution study in a controlled unilaterally nephrectomized mouse β cell depletion model. Semiquantitative measurement of the imaging results was performed using [(123)I]IPA to delineate the pancreas and [(111)In]Ex3 as a β cell tracer.
RESULTS: The uptake of [(123)I]IPA was highest in the pancreas. Aside from the kidneys, the uptake of [(111)In]Ex3 was highest in the pancreas and lungs. Autoradiography showed only uptake of [(111)In]Ex3 in insulin-expressing cells. Semiquantitative measurement of [(111)In]Ex3 in the SPECT images based on the delineation of the pancreas with [(123)I]IPA showed a high correlation with the [(111)In]Ex3 uptake data of the pancreas obtained by dissection. A strong positive correlation was observed between the relative insulin positive area and the pancreas-to-blood ratios of [(111)In]Ex3 uptake as determined by counting with a gamma counter and the semiquantitative analysis of the SPECT images.
CONCLUSIONS: [(123)I]IPA is a promising tracer to delineate pancreatic tissue on SPECT images. It shows a high uptake in the pancreas as compared to other abdominal tissues. This study also demonstrates the feasibility and accuracy to measure the β cell mass in vivo in an animal model of diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25070262     DOI: 10.1007/s11307-014-0771-y

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  31 in total

1.  A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.

Authors:  Martin Gotthardt; Georg Lalyko; Julliëtte van Eerd-Vismale; Boris Keil; Tino Schurrat; Michael Hower; Peter Laverman; Thomas M Behr; Otto C Boerman; Burkhard Göke; Martin Béhé
Journal:  Regul Pept       Date:  2006-08-22

2.  Improved quantification in single-pinhole and multiple-pinhole SPECT using micro-CT information.

Authors:  Christian Vanhove; Michel Defrise; Axel Bossuyt; Tony Lahoutte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-14       Impact factor: 9.236

3.  Pancreatic beta-cell mass or beta-cell function? That is the question!

Authors:  Jean-Claude Henquin; Erol Cerasi; Suad Efendic; Donald F Steiner; Christian Boitard
Journal:  Diabetes Obes Metab       Date:  2008-11       Impact factor: 6.577

Review 4.  Development of radiotracers for the determination of the beta-cell mass in vivo.

Authors:  Maarten Brom; Karolina Andrałojć; Wim J G Oyen; Otto C Boerman; Martin Gotthardt
Journal:  Curr Pharm Des       Date:  2010-05       Impact factor: 3.116

5.  123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.

Authors:  Veerle Kersemans; Bart Cornelissen; Ken Kersemans; Matthias Bauwens; Rudi A Dierckx; Bart De Spiegeleer; John Mertens; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-30       Impact factor: 9.236

6.  Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss.

Authors:  Fabrizio Thorel; Virginie Népote; Isabelle Avril; Kenji Kohno; Renaud Desgraz; Simona Chera; Pedro L Herrera
Journal:  Nature       Date:  2010-04-04       Impact factor: 49.962

7.  T-type amino acid transporter TAT1 (Slc16a10) is essential for extracellular aromatic amino acid homeostasis control.

Authors:  Luca Mariotta; Tamara Ramadan; Dustin Singer; Adriano Guetg; Brigitte Herzog; Claudia Stoeger; Manuel Palacín; Tony Lahoutte; Simone M R Camargo; François Verrey
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

8.  Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test.

Authors:  Fida Bacha; Neslihan Gungor; Silva A Arslanian
Journal:  J Pediatr       Date:  2008-02-04       Impact factor: 4.406

9.  Efforts to develop methods for in vivo evaluation of the native beta-cell mass.

Authors:  S Schneider
Journal:  Diabetes Obes Metab       Date:  2008-11       Impact factor: 6.577

10.  Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass.

Authors:  Marie-Line Peyot; Emilie Pepin; Julien Lamontagne; Martin G Latour; Bader Zarrouki; Roxane Lussier; Marco Pineda; Thomas L Jetton; S R Murthy Madiraju; Erik Joly; Marc Prentki
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

View more
  10 in total

Review 1.  In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use.

Authors:  Olof Eriksson; Maren Laughlin; Maarten Brom; Pirjo Nuutila; Michael Roden; Albert Hwa; Riccardo Bonadonna; Martin Gotthardt
Journal:  Diabetologia       Date:  2016-04-19       Impact factor: 10.122

2.  Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4.

Authors:  Naotaka Fujita; Hiroyuki Fujimoto; Keita Hamamatsu; Takaaki Murakami; Hiroyuki Kimura; Kentaro Toyoda; Hideo Saji; Nobuya Inagaki
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.191

3.  SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments.

Authors:  Wael A Eter; Saba Parween; Lieke Joosten; Cathelijne Frielink; Maria Eriksson; Maarten Brom; Ulf Ahlgren; Martin Gotthardt
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

4.  Simultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesions.

Authors:  Zhide Guo; Mengna Gao; Deliang Zhang; Yesen Li; Manli Song; Rongqiang Zhuang; Xinhui Su; Guibing Chen; Ting Liu; Pingguo Liu; Hua Wu; Jin Du; Xianzhong Zhang
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

5.  Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin.

Authors:  Stefanie M A Willekens; Lieke Joosten; Otto C Boerman; Alexander Balhuizen; Decio L Eizirik; Martin Gotthardt; Maarten Brom
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

6.  Species differences in pancreatic binding of DO3A-VS-Cys40-Exendin4.

Authors:  Olof Eriksson; Ulrika Rosenström; Ram K Selvaraju; Barbro Eriksson; Irina Velikyan
Journal:  Acta Diabetol       Date:  2017-09-11       Impact factor: 4.280

7.  Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with 111In-labeled exendin-4.

Authors:  Keita Hamamatsu; Hiroyuki Fujimoto; Naotaka Fujita; Takaaki Murakami; Masaharu Shiotani; Kentaro Toyoda; Nobuya Inagaki
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

Review 8.  Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics.

Authors:  Irina Velikyan; Olof Eriksson
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 9.  Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.

Authors:  Stephane Demine; Michael L Schulte; Paul R Territo; Decio L Eizirik
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

Review 10.  Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.

Authors:  Takaaki Murakami; Hiroyuki Fujimoto; Nobuya Inagaki
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.